Related Experiment Video
Updated: Feb 5, 2026

Measuring Proliferation of Vascular Smooth Muscle Cells Using Click Chemistry
Published on: October 30, 2019
Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic
Nicholas E Buglak1, Wulin Jiang2, Edward S M Bahnson3
1Department of Surgery, Division of Vascular Surgery, University of North Carolina at Chapel Hill, NC 27599, USA; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, NC 27599, USA; Curriculum in Toxicology & Environmental Medicine, University of North Carolina at Chapel Hill, NC 27599, USA.
Abstract:
Atherosclerosis remains the number one cause of death and disability worldwide. Atherosclerosis is treated by revascularization procedures to restore blood flow to distal tissue, but these procedures often fail due to restenosis secondary to neointimal hyperplasia. Diabetes mellitus is a metabolic disorder that accelerates both atherosclerosis development and onset of restenosis. Strategies to inhibit restenosis aim at reducing neointimal hyperplasia by inhibiting vascular smooth muscle cell (VSMC) proliferation and migration. Since increased production of reactive oxygen species promotes VSMC proliferation and migration, redox intervention to maintain vascular wall redox homeostasis holds the potential to inhibit arterial restenosis. Cinnamic aldehyde (CA) is an electrophilic Nrf2 activator that has shown therapeutic promise in diabetic rodent models. Nrf2 is a transcription factor that regulates the antioxidant response. Therefore, we hypothesized that CA would activate Nrf2 and would inhibit neointimal hyperplasia after carotid artery balloon injury in the Zucker Diabetic Fatty (ZDF) rat. In primary ZDF VSMC, CA inhibited cell growth by MTT with an EC50 of 118 ± 7 μM. At a therapeutic dose of 100 μM, CA inhibited proliferation of ZDF VSMC in vitro and reduced the proliferative index within the injured artery in vivo, as well as migration of ZDF VSMC in vitro. CA activated the Nrf2 pathway in both ZDF VSMC and injured carotid arteries while also increasing antioxidant defenses and reducing markers of redox dysfunction. Additionally, we noted a significant reduction of neutrophils (69%) and macrophages (78%) within the injured carotid arteries after CA treatment. Lastly, CA inhibited neointimal hyperplasia evidenced by a 53% reduction in the intima:media ratio and a 61% reduction in vessel occlusion compared to arteries treated with vehicle alone. Overall CA was capable of activating Nrf2, and inhibiting neointimal hyperplasia after balloon injury in a rat model of diabetic restenosis.
Insights
Cinnamic aldehyde (CA) effectively inhibits neointimal hyperplasia in diabetic rats by activating Nrf2, reducing vascular smooth muscle cell proliferation, and decreasing vessel occlusion. This offers a promising therapeutic strategy for preventing restenosis after revascularization procedures.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Pharmacology
Background:
- Atherosclerosis is a leading cause of death, with restenosis after revascularization procedures being a significant complication.
- Diabetes mellitus exacerbates atherosclerosis and restenosis by promoting vascular smooth muscle cell (VSMC) proliferation and migration.
- Reactive oxygen species (ROS) drive VSMC proliferation; thus, redox intervention is a potential strategy to inhibit restenosis.
Purpose of the Study:
- To investigate the efficacy of cinnamic aldehyde (CA), an Nrf2 activator, in inhibiting neointimal hyperplasia in a rat model of diabetic restenosis.
- To determine if CA activates the Nrf2 pathway and modulates redox homeostasis in vascular cells and tissues.
Main Methods:
- Primary Zucker Diabetic Fatty (ZDF) VSMC were used to assess CA's effect on cell growth and migration in vitro.
- A carotid artery balloon injury model in ZDF rats was employed to evaluate CA's in vivo efficacy.
- Nrf2 activation, antioxidant defenses, inflammatory cell infiltration, and neointimal hyperplasia were quantified.
Main Results:
- CA inhibited ZDF VSMC proliferation (EC50 = 118 ± 7 μM) and migration in vitro.
- In vivo, CA reduced the proliferative index in injured arteries and significantly decreased neutrophil and macrophage infiltration.
- CA treatment resulted in a 53% reduction in the intima:media ratio and a 61% decrease in vessel occlusion.
Conclusions:
- Cinnamic aldehyde activates the Nrf2 pathway and enhances antioxidant defenses.
- CA effectively inhibits neointimal hyperplasia and vessel occlusion in a diabetic rat model of restenosis.
- CA demonstrates therapeutic potential for preventing diabetic restenosis by targeting VSMC proliferation and inflammation.
Related Concept Videos
Functions of Smooth Muscles
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Structure and Organization of Smooth Muscles
Structure of smooth muscle cell
Smooth muscle cells are spindle-shaped with tapering ends and a...
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation

